Showing results (861-870 of 9,004) with videos related to
Sort By:
Pageof 901
European Journal of Clinical Pharmacology|January 1, 1992
Pharmacokinetics of the active metabolite of the prodrug repirinast in healthy Caucasian volunteers after a single oral doseD Beermann, H G Schaefer, M Wargenau, et al.European Journal of Clinical Pharmacology|December 16, 2003
Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patientsEhab S EL Desoky, Eliane Fuseau, Salah EL Din Amry, et al.European Journal of Clinical Pharmacology|June 27, 2003
Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged > or =80 yearsSven E Nilsson, Boo Johansson, Sanna Takkinen, et al.European Journal of Clinical Pharmacology|August 5, 2003
A naturalistic cohort study on effectiveness, safety and usage pattern of an over-the-counter nicotine patch. Cohort study on smoking cessationJoerg Hasford, Karl Olov Fagerstrom, Knut-Olav HausteinEuropean Journal of Clinical Pharmacology|May 14, 2003
Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) studyMiguel Quintana, Paul Hjemdahl, Alf Sollevi, et al.European Journal of Clinical Pharmacology|May 14, 2003
Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjectsUlf G Eriksson, Ulf Bredberg, Kristina Gislén, et al.European Journal of Clinical Pharmacology|May 14, 2003
Polymorphic drug metabolism (CYP2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients: a retrospective studyWim J Tamminga, Johan Wemer, Berend Oosterhuis, et al.European Journal of Clinical Pharmacology|March 1, 2003
CYP2D6*10 alleles do not determine plasma fluvoxamine concentration/dose ratio in Japanese subjectsKoichi Ohara, Shigeru Tanabu, Kazuhisa Ishibashi, et al.European Journal of Clinical Pharmacology|March 1, 2003
Identification of epoxybergamottin as a CYP3A4 inhibitor in grapefruit peelH Wangensteen, E Molden, H Christensen, et al.European Journal of Clinical Pharmacology|March 1, 2003
Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairmentS G Simonson, P D Martin, P Mitchell, et al.Pageof 901